Meribank Biotech Co., Ltd
4724
Rank in Stocks
#25372
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei... Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
Share Price
$0.27436013
Last synced: 2026-11-10
Market Cap
$26.33M
Change (1 day)
2.62%
Change (1 year)
-51.13%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Meribank Biotech Co., Ltd (4724)
Category
Healthcare
EPS for Meribank Biotech Co., Ltd (4724)
EPS as of June 2026 TTM: $-0.04
According to Meribank Biotech Co., Ltd's latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $-0.03, an increase over its 2024 EPS of $-0.04.
EPS history for Meribank Biotech Co., Ltd from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.04 | 48.33% |
| 2025 | $-0.03 | -21.76% |
| 2024 | $-0.04 | -44.07% |
| 2023 | $-0.06 | 22.92% |
| 2022 | $-0.05 | -10.20% |
| 2021 | $-0.06 | 61.98% |
| 2020 | $-0.04 | -3.97% |
| 2019 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -35,291.01% |
US
|
|
| $-7.07 | 15,787.64% |
US
|
|
| $-5.29 | 11,787.64% |
AU
|
|
| $12.88 | -29,044.04% |
BE
|
|
| $21.56 | -48,549.44% |
NL
|
Questions about Meribank Biotech Co., Ltd's earnings per share (EPS)
What is Meribank Biotech Co., Ltd's earnings per share (EPS)?
Meribank Biotech Co., Ltd's earnings per share (EPS) over the last twelve months is $-0.04, as of Jun 2026.
What was Meribank Biotech Co., Ltd's earnings per share (EPS) in 2025?
In 2025, Meribank Biotech Co., Ltd's earnings per share (EPS) was $-0.03, compared with $-0.04 in 2024.
How has Meribank Biotech Co., Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Meribank Biotech Co., Ltd's earnings per share (EPS) was highest in 2025 ($-0.03) and lowest in 2023 ($-0.06).
How does Meribank Biotech Co., Ltd's earnings per share (EPS) compare with similar companies?
Meribank Biotech Co., Ltd's earnings per share (EPS) ($-0.04) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.